New York, May 12, 2026, 15:05 EDT
The iShares MSCI World ETF edged lower on Tuesday, pulling back after hitting record highs as U.S. inflation numbers came in above forecasts. Investors were also keeping an eye on an MSCI index review set for later. URTH hovered around $200, off roughly 0.4%. That matched the dip in the SPDR S&P 500 ETF and fared a bit better than the iShares MSCI ACWI ETF, which slipped about 0.8%.
Not the best timing. According to the Bureau of Labor Statistics, the consumer price index climbed 0.6% in April and landed 3.8% higher than a year ago. Over the past 12 months, energy costs surged 17.9%, stirring up the rate-cut debate again—with global equity funds still heavily tilted toward AI and chip stocks.
URTH isn’t just about tech—it’s a wide-reaching fund, and its size is the story. According to BlackRock, the ETF had $8.02 billion in net assets, spread across 1,311 holdings, with a May 11 close at $200.88. Investors are paying a 0.24% expense ratio. Year to date through May 11, NAV return hit 8.27%.
MSCI plans to release the list of index additions and deletions from its May review just after 11 p.m. CEST, with adjustments reflecting the market close on May 29. The company also flagged a possible update to its free-float methodology, which could shift Foreign Inclusion Factor figures for certain stocks—free float referring to shares accessible to the general investing public.
The AI chip surge has tipped the scales. Samsung Electronics posted first-quarter operating profit of KRW 57.2 trillion, with KRW 53.7 trillion coming out of its Device Solutions arm. Reuters, last week, put Samsung’s market value over $1 trillion—only the second company in Asia to reach that milestone after TSMC.
For analysts, the CPI came down to rates, not just fuel. Oliver Pursche of Wealthspire Advisors told Reuters the data cemented expectations the Fed “not going to be able to lower rates this year.” At RSM, Joseph Brusuelas flagged “stagflation lite” as the base case. Guggenheim’s Matt Bush cited a mix of energy, tariffs, and AI-related spending pressures. Reuters
The Fed equation changed, too. Kevin Warsh was confirmed by the Senate on Tuesday to serve a 14-year stint as a Federal Reserve governor, according to Reuters. A separate vote could install him as Fed chair for a four-year term as early as Wednesday. Jerome Powell’s stint in the top job wraps up Friday.
Pharmaceuticals face a more gradual policy threat. In April, the White House announced tariffs targeting patented drug imports: a baseline 100% duty, with some countries under trade deals getting breaks, and rollout dates set for July 31 for big players on the initial list, and September 29 for the rest. Reuters later said 17 leading pharma firms secured tariff exemptions after settling on new pricing terms.
Still, the bearish outcome isn’t a sure thing. Oil prices dropping could ease inflation pressures; MSCI, if it makes only limited tweaks, might see index funds handle the reshuffle with little fuss. The risk? Energy prices refusing to budge, rates staying elevated, and index flows hitting already packed mega-caps all at once.
Right now, the MSCI World ETF isn’t behaving like the calm, steady core investors expect. Instead, it’s turned into a litmus test for three big unknowns: Can AI-fueled profits outpace inflation? Is the Fed trapped by sticky prices? Do index dynamics shift the game when so many are piled into the same global names?
